Company: GEHC
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001628280-25-017240
Chunk: 83

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 83
---
 which plans became effective as of the Spin-Off.

#### GE HEALTHCARE 2025 PROXY STATEMENT73

#### Independent Auditor

#### Review and Engagement
The Audit Committee is responsible for the appointment, compensation (including advance approval of the audit fee), retention, and oversight of the independent auditor that audits our financial statements and our internal control over financial reporting. In accordance with its charter, the Audit Committee has selected Deloitte, an independent registered public accounting firm, to be our auditors for the fiscal year ending December 31, 2025. The Audit Committee believes that this selection is in the best interests of GE HealthCare and its stockholders and, therefore, recommends to stockholders that they ratify that appointment.

Prior to the selection of Deloitte as the Company’s independent auditor, the Audit Committee considered many factors, including:

• Deloitte’s capability and expertise in addressing and advising on the breadth and complexity of our global operations

• Deloitte’s independence

• The appropriateness of Deloitte’s fees for audit and non- audit services

• Deloitte’s reputation for integrity and competence in the fields of accounting and auditing

• The level of service provided by the firm

A representative of Deloitte will be present at the Annual Meeting, will have the opportunity to make a statement if they desire to do so, and will be available to respond to appropriate stockholder questions.

#### 74GE HEALTHCARE 2025 PROXY STATEMENT

#### Independent Auditor

#### Audit Committee Report
The following report of the Audit Committee shall not be deemed to be “soliciting material” nor shall such information be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, and shall not otherwise be deemed filed under these acts, except to the extent we specifically incorporate by reference into such filings.

The Audit Committee reflects the Board’s commitment to active oversight throughout the organization. The Audit Committee met 10 times in 2024 to oversee the various matters under its remit, including:

• Financial performance and outlook

• Oversight of our external auditor

• Internal audit

• Pension

• Information technology and cybersecurity

• Compliance

• Litigation and investigations

• Treasury

Roles and Responsibilities: The Audit Committee, on behalf of the Board, oversees GE HealthCare’s accounting and financial reporting processes, the integrity of the Company’s financial statements, and the annual independent audit of the Company’s financial statements. The Audit Committee oversees